Use of oral contraceptives in three European countries: a population-based multi-database study

REFERENCES

• Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: a review of the literature. Eur J Contracept Reproduct Health Care 2010;15(Suppl. 2):S19–31.
   PubMed Web of Science ®Google Scholar
• Chadwick KD, Burkman RT, Tornesi BM, Mahadevan B. Fifty years of ‘the pill’: risk reduction and discovery of benefits beyond contraception, reflections, and forecast. Toxicol Sci 2012;125:2–9.
   PubMed Web of Science ®Google Scholar
• Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J 1969;2:651–7.
   PubMed Web of Science ®Google Scholar
• United Nations DoEaSA, Population Division, World Contraceptive Use 2009. (POP/DB/CP/Rev2009).
   Google Scholar
• Herings RMC. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in the Netherlands. Utrecht: Utrecht University 1993.
   Google Scholar
• Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Meth Inform Med 1999;38:339–44.
   PubMed Web of Science ®Google Scholar
• van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, Vreugdenhil G, Pruijt JF, Coebergh JW, et al. New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer 2010;46:395–404.
   PubMed Web of Science ®Google Scholar
• Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Informatics Primary Care 2011;19:251–55.
   PubMedGoogle Scholar
• Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Safety 2007;16:393–401.
   PubMed Web of Science ®Google Scholar
• Gini R, Schuemie MJ, Francesconi P, Lapi F, Cricelli I, Pasqua A, et al. Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases? PLoS one 2014;9:e95419.
   PubMed Web of Science ®Google Scholar
• Norwegian Institute of Public Health, WHO Collaborating Centre for Drug Statistics Methodology. International language for drug utilization research. Accessed 2 June 2013 from: www.whocc.no/
   Google Scholar
• Avillach P, Dufour JC, Diallo G, Salvo F, Joubert M, Thiessard F, et al. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: A contribution from the EU-ADR project. J Am Med Informatics Ass 2013;20:446–52.
   PubMed Web of Science ®Google Scholar
• Avillach P, Joubert M, Thiessard F, Trifiro G, Dufour JC, Pariente A, et al. Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: A contribution to the European EU-ADR project. Stud Health Technol Informatics 2010;160:1085–9.
   PubMedGoogle Scholar
• Avillach P, Mougin F, Joubert M, Thiessard F, Pariente A, Dufour JC, et al. A semantic approach for the homogeneous identification of events in eight patient databases: A contribution to the European eu-ADR project. Stud Health Technol informatics 2009;150:190–4.
   PubMedGoogle Scholar
• Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: The EU-ADR Project. Pharmacoepidemiol Drug Safety 2011;20:1–11.
   PubMed Web of Science ®Google Scholar
• Rashed AN, Hsia Y, Wilton L, Ziller M, Kostev K, Tomlin S. Trends and patterns of hormonal contraceptive prescribing for adolescents in primary care in the UK. J Family Planning Reproduct Health Care/Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2015;41:216–22.
   PubMed Web of Science ®Google Scholar
• Kurver MJ, van der Wijden CL, Burgers J. [Summary of the Dutch College of General Practitioners’ practice guideline ‘Contraception’]. Nederlands tijdschrift voor geneeskunde 2012;156:A5083.
   PubMedGoogle Scholar
• Faculty of Sexual and Reproductive Healthcare. Clinical guidance. Combined hormonal contraception 2012. Accessed 12 June 2013 from: www.fsrh.org/pdfs/CEUGuidanceCombinedHormonalContraception.pdf
   Google Scholar
• Faculty of Sexual and Reproductive Healthcare. Clinical guidance. Progestogen-only pills 2009. Accessed 12 June 2013 from: www.fsrh.org/pdfs/CEUGuidanceProgestogenOnlyPill09.pdf
   Google Scholar
• Cea-Soriano L, Garcia Rodriguez LA, Machlitt A, Wallander MA. Use of prescription contraceptive methods in the UK general population: A primary care study. BJOG 2014;121:53–60; discussion 61.
   PubMed Web of Science ®Google Scholar
• Prevenzione delle complicanze trombotiche associate all’uso di estroprogestinici in età riproduttiva (consensus conference 2). Sistema nazionale per le linee guida 2009.
   Google Scholar
• Dunn N. The risk of deep venous thrombosis with oral contraceptives containing drospirenone. BMJ 2011;342:d2519.
   PubMed Web of Science ®Google Scholar
• Hannaford PC. Epidemiology of the contraceptive pill and venous thromboembolism. Thrombosis Res 2011;127(Suppl. 3):S30–4.
   PubMed Web of Science ®Google Scholar
• Rott H. Thrombotic risks of oral contraceptives. Curr Opin Obstetr Gynecol 2012;24:235–40.
   PubMed Web of Science ®Google Scholar
• van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;339:b2921.
   PubMed Web of Science ®Google Scholar
• Istituto Superiore di Sanità. Rapporto nazionale anno 2011. L’uso dei farmaci in Italia 2012. Accessed 12 June 2013 from: www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmed-2011
   Google Scholar